SINS OF OMISSION AND OBFUSCATION: IQWIG'S GUIDELINES ON ECONOMIC EVALUATION METHODS

被引：20

作者：

Sculpher, Mark ^{[1
]}

Claxton, Karl ^{[1
,2
]}

机构：

[1] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England

[2] Univ York, Dept Econ & Related Studies, York YO10 5DD, N Yorkshire, England

来源：

HEALTH ECONOMICS | 2010年 / 19卷 / 10期

关键词：

D O I：

10.1002/hec.1645

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：1132 / 1136

页数：5

共 6 条

[1] Valuing health states for use in cost-effectiveness analysis [J].

Brazier, John .

PHARMACOECONOMICS, 2008, 26 (09) :769-779

[2] THE EFFICIENCY FRONTIER APPROACH TO ECONOMIC EVALUATION OF HEALTH-CARE INTERVENTIONS [J].

Caro, J. Jaime ;

Nord, Erik ;

Siebert, Uwe ;

McGuire, Alistair ;

McGregor, Maurice ;

Henry, David ;

de Pouvourville, Gerard ;

Atella, Vincenzo ;

Kolominsky-Rabas, Peter .

HEALTH ECONOMICS, 2010, 19 (10) :1117-1127

[3]

Claxton K, 2010, 54 CHE

[4] IQWiG:: an opportunity lost? [J].

Jonsson, Bengt .

EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2008, 9 (03) :205-207

[5] The NICE cost-effectiveness threshold - What it is and what that means [J].

McCabe, Christopher ;

Claxton, Karl ;

Culyer, Anthony J. .

PHARMACOECONOMICS, 2008, 26 (09) :733-744

[6] Use of indirect and mixed treatment comparisons for technology assessment [J].

Sutton, Alex ;

Ades, A. E. ;

Cooper, Nicola ;

Abrams, Keith .

PHARMACOECONOMICS, 2008, 26 (09) :753-767

← 1 →